Aerobic activity can reduce the risk of metastatic cancer by 72%

by Tel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study at Tel Aviv University found that aerobic exercise can reduce the risk of metastatic cancer by 72%. According to the researchers

Updated on: February 23,2024

Aerobic activity can reduce the risk of metastatic cancer by 72%

by Tel Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study at Tel Aviv University found that aerobic exercise can reduce the risk of metastatic cancer by 72%. According to the researchers

Updated on:February 23,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on: March 01,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on:March 01,2024

Swapping meat for 'mycoprotein' may protect against bowel cancer

by Northumbria UniversityVegetarian chilli con carne made with Quorn mycoprotein. Credit: QuornResearchers from Northumbria University have found that swapping red and processed meat for Quorn&#3

Updated on: February 23,2024

Swapping meat for 'mycoprotein' may protect against bowel cancer

by Northumbria UniversityVegetarian chilli con carne made with Quorn mycoprotein. Credit: QuornResearchers from Northumbria University have found that swapping red and processed meat for Quorn&#3

Updated on:February 23,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on: March 01,2024

Study shows why a common form of immunotherapy fails, and suggests solution

by Georgetown University Medical CenterSamir N. Khleif, MD, director of The Loop Immuno-Oncology Laboratory at Georgetown Lombardi, led the research team that published new research on checkpoint

Updated on:March 01,2024

Rural residence tied to poorer adherence to radiation treatment for cancer

Rural residence is associated with both radiation treatment (RT) nonadherence and poorer overall survival among cancer patients, according to a study recently published in theInternational Journ

Updated on: January 02,2024

Rural residence tied to poorer adherence to radiation treatment for cancer

Rural residence is associated with both radiation treatment (RT) nonadherence and poorer overall survival among cancer patients, according to a study recently published in theInternational Journ

Updated on:January 02,2024

Subtyping of breast cancer cell lines reveals insights into cancer-relevant genes

by Manuela Schüngel, Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbHWaterfall plot depicting recurrent non-synonymous mutations in BC cell lines. Mutations were calle

Updated on: March 30,2024

Subtyping of breast cancer cell lines reveals insights into cancer-relevant genes

by Manuela Schüngel, Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbHWaterfall plot depicting recurrent non-synonymous mutations in BC cell lines. Mutations were calle

Updated on:March 30,2024

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Updated on: September 27,2024

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Updated on:September 27,2024

Reversing chemotherapy resistance in pancreatic cancer

byStanford UniversityCredit: CC0 Public DomainPancreatic cancer is a particularly aggressive and difficult-to-treat cancer, in part because it is often resistant to chemotherapy. Now, researcher

Updated on: July 05,2024

Reversing chemotherapy resistance in pancreatic cancer

byStanford UniversityCredit: CC0 Public DomainPancreatic cancer is a particularly aggressive and difficult-to-treat cancer, in part because it is often resistant to chemotherapy. Now, researcher

Updated on:July 05,2024

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Updated on: May 21,2024

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Updated on:May 21,2024

Team discovers broken 'brake' of cancer mutation machine

by UT Southwestern Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.010Loss of a gene known as SYNCRIP in prostate cancer tumors unleashes cellular machinery that

Updated on: February 03,2024

Team discovers broken 'brake' of cancer mutation machine

by UT Southwestern Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.010Loss of a gene known as SYNCRIP in prostate cancer tumors unleashes cellular machinery that

Updated on:February 03,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on: June 08,2024

Researchers exploit DNA amplification in cancer to halt chemoresistance

by Stony Brook UniversityGábor Balázsi, in his Biomedical Engineering laboratory with Rafal Krzysztoń, PhD, and Yiming Wan, PhD, both first co-authors on thePNASpaper. Credit: John Gr

Updated on:June 08,2024

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on: April 07,2024

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on:April 07,2024